Requires medicaid and insurers to include coverage for testing of PFAS levels in blood

This bill requires New York Medicaid and private health insurers to cover blood testing for PFAS (perfluoroalkyl and polyfluoroalkyl substances) when ordered by a licensed physician or healthcare provider. It applies to all comprehensive health insurance plans, including Medicaid, and defines PFAS as specific chemicals linked to environmental contamination. Coverage must be provided for the testing itself, though the bill notes that Medicaid coverage depends on available federal funding. The law takes effect January 1, 2027, for new or renewed policies.